Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

OXiGENE Reports Encouraging Data From Phase 2 Trial of ZYBRESTAT(TM) in Non-small Cell Lung Cancer
Yahoo/Globe NewsWire
Sunday, June 5, 2011 - 10:07am
tags:
Oxigene, Zybrestat, non-small cell lung cancer
Exelixis Drug Shrinks Ovarian Cancer
The Street
Sunday, June 5, 2011 - 10:06am
tags:
Exelixis, cabozantinib, ovarian cancer
Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting
Yahoo/BusinessWire
Sunday, June 5, 2011 - 10:04am
tags:
Alnylam, liver cancer, ALN-VSP, RNAi
Incyte Announces Ruxolitinib (INC424) Shows Significant Clinical Benefit for Myelofibrosis Patients in Two Phase III Studies at ASCO Annual Meeting
Yahoo/BusinessWire
Sunday, June 5, 2011 - 10:03am
tags:
Incyte, ruxolitinib, INC424, myelofibrosis
Corcept Therapeutics Announces Detailed Findings From Phase 3 Study Which Show CORLUX Significantly Improves Clinical and Metabolic Manifestations of Cushing's Syndrome
Yahoo/MarketWire
Sunday, June 5, 2011 - 10:01am
tags:
Corcept Therapeutics, Corlux, Cushing's syndrome
Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy
Yahoo/PR NewsWire
Sunday, June 5, 2011 - 9:58am
tags:
metreleptin, diabetes, partial lipodystrophy, Amylin
ASCO '11: Roche, Avastin and Ovarian Cancer
The Street
Sunday, June 5, 2011 - 9:56am
tags:
Roche, Avastin, ovarian cancer
Bionovo's Menerba Phase 2 trial data to be presented at Annual World Congress on Menopause
news-medical.net
Saturday, June 4, 2011 - 11:24am
tags:
Bionovo, Menerba, menopause
'UK pharmaceutical industry in crisis'
Press TV
Saturday, June 4, 2011 - 11:23am
tags:
UK
Mylan receives US FDA nod for generic Effexor XR capsules
Pharmabiz
Saturday, June 4, 2011 - 11:15am
tags:
Mylan, Effexor XR
Tarceva nearly doubled the time people with a genetically distinct type of lung cancer lived without their disease getting worse
Pipeline Review
Saturday, June 4, 2011 - 11:13am
tags:
Tarceva, lung cancer
Takeda Drops Suit Over Macleods' Actos ANDA
Law360
Saturday, June 4, 2011 - 11:06am
tags:
Takeda, Actos, Macleod
Forest Laboratories - Best Performing Pharmaceutical
Trader's Huddle
Saturday, June 4, 2011 - 11:04am
tags:
Forest Labs
Five-Year Follow-Up Data for SPRYCEL® (dasatinib) 100 mg Once Daily Demonstrated 78 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia Resistant or Intolerant to Gleevec®*
BusinessWire
Saturday, June 4, 2011 - 10:53am
tags:
Sprycel, Bristol-Myers Squibb, leukemia
Pfizer And Big Pharma Peers Eye Post-Blockbuster Era
Investor's Business Daily
Saturday, June 4, 2011 - 10:34am
tags:
Pfizer, Big Pharma
Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Reduction in Life-Threatening Venous Thrombo-Embolism
Yahoo/PR NewsWire
Saturday, June 4, 2011 - 10:29am
tags:
Sanofi, Semuloparin, Venous Thrombo-Embolism
J&J Ordered to Pay $327 Million Over Deceptive-Marketing Claims
Bloomberg
Saturday, June 4, 2011 - 10:26am
tags:
JNJ, Risperdal, legal
Cancer-Drug Trials Matching Medicines to Mutations Boost Odds of Success
Bloomberg
Saturday, June 4, 2011 - 10:25am
tags:
cancer
A Hazy Future For Big Pharma
Yahoo/Investor's Business Daily
Saturday, June 4, 2011 - 10:08am
tags:
Big Pharma
FDA Bullies Obesity Drugmakers
Motley Fool
Saturday, June 4, 2011 - 10:06am
tags:
Orexigen, Contrave, Vivus, Qnexa, Arena Pharmaceuticals, obesity, weight loss

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.